Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the united states: results observed with the first 100 consecutive cases of depression at an Academic Medical Center

Journal of Clinical Psychiatry

Volumn 73, Issue 4, 2012, Pages

  Connolly, K Ryan ^a,b   Helmer, Amanda ^b   Cristancho, Mario A ^b   Cristancho, Pilar ^c   O'Reardon, John P ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PRACTICE; COHORT ANALYSIS; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUICK INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; RETROSPECTIVE STUDY; SHEEHAN DISABILITY SCALE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 84860593384     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07413     Document Type: Article

References (27)

1. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216. PubMed (Pubitemid 350060890)
2. Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009;39(1):65-75. PubMed
3. Schutter DJ. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med. 2010;40(11):1789-1795. PubMed
4. Gross M, Nakamura L, Pascual-Leone A, et al. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? a systematic review and meta-analysis comparing the recent vs the earlier rTMS studies. Acta Psychiatr Scand. 2007;116(3):165-173. PubMed (Pubitemid 47106664)
5. Lam RW, Chan P, Wilkins-Ho M, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. Can J Psychiatry. 2008;53(9):621-631. PubMed
6. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):10-17. PubMed
7. Rossi S, Hallett M, Rossini PM, et al; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008-2039. doi:10.1016/j.clinph.209.08.016 PubMed
8. George MS, Wassermann EM, Kimbrell TA, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry. 1997;154(12):1752-1756. PubMed (Pubitemid 27516596)
9. Beam W, Borckardt J, Reeves S, et al. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimulat. 2009;2(1):50-54. doi:10.1016/j.brs.208.09.06
10. Nahas Z, Teneback CC, Kozel A, et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci. 2001;13(4):459-470. doi:10.176/api.neuropsych.13.4.459 PubMed (Pubitemid 33140919)
11. McConnell KA, Nahas Z, Shastri A, et al. The transcranial magnetic stimulation motor threshold depends on the distance from coil to underlying cortex: a replication in healthy adults comparing two methods of assessing the distance to cortex. Biol Psychiatry. 2001;49(5):454-459. doi:10.1016/S06-323(0) 01039-8 PubMed (Pubitemid 32234308)
12. Guy W. ECDEU Assessment Manual for Psychopharmacology-Revised. US Department of Health, Education, and Welfare publication (ADM 76- 338). Rockville, MD: National Institute of Mental Health; 1976:218-222.
13. Leon AC, Shear MK, Klerman GL, et al. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression. J Clin Psychopharmacol. 1993;13(5):327-331. doi:10.1097/04714-19310-05 PubMed (Pubitemid 23313359)
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
15. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. doi:10.1016/S06-323(02)0186-8 PubMed (Pubitemid 37289444)
16. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561-571. doi:10.101/archpsyc.1961. 017101203104 PubMed
17. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893-897. doi:10.1037/02-06X.56.6.893 PubMed (Pubitemid 19008360)
18. In Sheehan DV. The Anxiety Disease. New York, NY: Charles Scribner; 1983:151.
19. O'Reardon JP, Cristancho P, Pilania P. et al. Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion. Depress Anxiety. 2007;24(8):537-544. PubMed (Pubitemid 350274854)
20. Hadley D, Anderson BS, Borckardt JJ, et al. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011;27(1):18-25. doi:10.1097/YCT.0b013e3181ce1a8c PubMed
21. Avery DH, Isenberg KE, Sampson SM, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry. 2008;69(3):441-451. PubMed (Pubitemid 351549398)
22. Dell'Osso B, Mundo E, D'Urso N, et al. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disord. 2009;11(1):76-81. PubMed
23. Dolberg OT, Dannon PN, Schreiber S, et al. Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disord. 2002;4(suppl 1):94-95. PubMed
24. Nahas Z, Kozel FA, Li X, et al. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003;5(1):40-47. PubMed (Pubitemid 36621632)
25. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34(2):522-534. PubMed
26. Fregni F, Marcolin MA, Myczkowski M, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2006;9(6):641-654. PubMed (Pubitemid 46127397)
27. Slotema CW, Blom JD, Hoek HW, et al. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? a meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71(7):873-884. doi:10.408/JCP.08m04872gre PubMed